COMMUNIQUÉS West-GlobeNewswire

EDAP TMS SA : EDAP TMS SA to Announce Third Quarter 2018 Financial Results on Wednesday, November 14
06/11/2018
LYON, France, November 6, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the third quarter and nine months ended September [...]
Jounce Therapeutics to Announce Third Quarter 2018 Financial Results and Host Conference Call on Tuesday, November 13, 2018
06/11/2018
CAMBRIDGE, Mass., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, [...]
Distinguished Physicians Join Biotricity’s Newly Formed Scientific and Medical Alliance Board
06/11/2018
Experts to Help Drive Improvements in Technology and Support the Development of New Solutions REDWOOD CITY, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB : BTCY ), a medical diagnostic and consumer [...]
GBT Announces New Employment Inducement Grants
06/11/2018
SOUTH SAN FRANCISCO, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT or the Company) (NASDAQ: GBT) today announced that, on November 1, 2018, the compensation committee of the Company’s [...]
SciCann Therapeutics Announces Positive ISA Report for “Steady Stomach” CBD Combination Therapy Patent
06/11/2018
TORONTO, Nov. 06, 2018 (GLOBE NEWSWIRE) -- SciCann Therapeutics Inc. (“ SciCann ”) announced today it has received a positive International Search Authority (ISA) report from the Patent Cooperation Treaty (PCT) for its [...]
AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
06/11/2018
WALTHAM, Mass., Nov. 06, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that company management will participate in the following investor conferences: Jefferies London Healthcare [...]
ContraVir Pharmaceuticals to Present Two Posters at The Liver Meeting® 2018, Hosted by the American Association for the Study of Liver Diseases
06/11/2018
EDISON, N.J., Nov. 06, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of liver [...]
Progressive Care Inc. Garners International News Coverage in Top Pharmacy Trade Publication for Its Proprietary Tele-Pharmacy Platform
06/11/2018
MIAMI, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that it has garnered notable international media coverage in top [...]
Daré to Host Third Quarter 2018 Financial Results Conference Call and Webcast
06/11/2018
SAN DIEGO, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s biopharmaceutical company, today announced that it will host a conference call and live webcast at 8:30 a.m. [...]
Aeterna Zentaris Settles Dispute with Cogas Consulting, LLC
06/11/2018
CHARLESTON, S.C., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX: AEZS) and Cogas Consulting, LLC have amicably resolved their dispute with Aeterna Zentaris Inc. agreeing to make a payment to [...]
Iovance Biotherapeutics Announces Updated Phase 2 Clinical Data from the Lifileucel Metastatic Melanoma Trial at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting
06/11/2018
38% Objective Response Rate (ORR) demonstrated in 47 Metastatic Melanoma patients who were unsuccessfully treated with a prior PD-1 blocking antibody Median Duration of Response (DOR) of 6.4 Months Data selected for [...]
Transactions in relation to share buyback program
06/11/2018
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
ProMIS Neurosciences Discusses Critical Importance of Selectively Targeting the Root Cause of Alzheimer’s Disease
06/11/2018
Narrated white paper reveals lessons learned from 15 years of drug development; pressing need to selectively target the toxic oligomer TORONTO and CAMBRIDGE, Mass., Nov. 06, 2018 (GLOBE NEWSWIRE) -- ProMIS Neurosciences [...]
Atara Biotherapeutics Announces Third Quarter 2018 Financial Results and Recent Operational Progress
06/11/2018
SOUTH SAN FRANCISCO, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
Kura Oncology to Participate in Two Upcoming Investor Conferences
06/11/2018
SAN DIEGO, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that Troy [...]
OpGen Completes Specimen Accrual and Testing in Acuitas® Clinical Verification Study
06/11/2018
Study evaluated potential utility in management of complicated urinary tract infections; Analysis and peer-reviewed manuscript preparation are underway GAITHERSBURG, Md., Nov. 06, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. ( [...]
Spark Therapeutics Reports Third Quarter 2018 Financial Results and Recent Business Progress
06/11/2018
PHILADELPHIA, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ: ONCE), a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, announced today [...]
Otonomy Presents Data Highlighting Potential of OTO-413, an Otic Sustained-Exposure Formulation of BDNF, to Treat Hearing Loss
06/11/2018
Society for Neuroscience Features OTO-413 Presentation as Neuroscience 2018 Hot Topic SAN DIEGO, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development [...]
Vericel Reports Record Third Quarter Revenues of $22.5 Million and Raises Full Year 2018 Revenue Guidance
06/11/2018
58% Revenue Growth Over Third Quarter 2017 Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the [...]

Pages